Dr. Arend Discusses MSI Testing in Gynecologic Malignancies

Rebecca C. Arend, MD
Published: Wednesday, Aug 09, 2017



Rebecca C. Arend, MD, assistant professor, UAB School of Medicine, UAB Department of Obstetrics and Gynecology, UAB Comprehensive Cancer Center, discusses microsatellite instability (MSI) testing in patients with gynecologic malignancies.

Arend says all of her patients with gynecologic malignancies undergo MSI testing at their first recurrence.

When trials come along that these patients are eligible for, she can then recommend them accordingly.
 


Rebecca C. Arend, MD, assistant professor, UAB School of Medicine, UAB Department of Obstetrics and Gynecology, UAB Comprehensive Cancer Center, discusses microsatellite instability (MSI) testing in patients with gynecologic malignancies.

Arend says all of her patients with gynecologic malignancies undergo MSI testing at their first recurrence.

When trials come along that these patients are eligible for, she can then recommend them accordingly.
 



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesJan 30, 20182.0
Medical Crossfire®: The Expanding Role of PARP Inhibitors in the Treatment of Ovarian Cancers – Current Strategies and Future DirectionJan 30, 20181.5
Publication Bottom Border
Border Publication
x